✦ LIBER ✦

669 A phase III randomized trial of bendamustinehydrochloride, methotrexate, and 5-FU (BMF) versus CMF as first-line treatment of patients with metastatic breast cancer

✍ Scribed by G. von Minckwitz; I. Chemozemsky; R. Souchon; N. Stuart; J. Vermorken; K. Merkle; M. Kaufmann

Book ID: 118620841
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 141 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90700-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone, 5-fluorouracil, and high d

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma : A randomized Phase II trial

✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding

Randomized open-label phase III multicen

Randomized open-label phase III multicenter trial comparing TAXOL®/doxorubicin (AT) versus 5-fluorouracil/doxorubicin and cyclophosphamide (FAC) as a first line treatment for patients with metastatic breast cancer

✍ Płuż;zańska, A.; Jassem, J.; Jelič, S.; Gorbunova, V.; Mrsič-Krmpotič, Z.; Berzi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Activity and safety of vinorelbine and c

Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer – a phase II trial

✍ R. Palumbo; A. Bernardo; M. Strada; C. Teragni; G. Poggi; M. Frascaroli; A. Amat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Sunitinib Plus Paclitaxel Versus Bevaciz

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

✍ Nicholas J. Robert; Mansoor N. Saleh; Devchand Paul; Daniele Generali; Laurent G 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 798 KB

Randomized phase III trial of adjuvant e

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer

✍ Dino Amadori; Rosella Silvestrini; Mario De Lena; Francesco Boccardo; Andrea Roc 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 485 KB

Capecitabine plus paclitaxel versus epir

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group

✍ Hans-Joachim Lück, Andreas Du Bois, Sibylle Loibl, Iris Schrader, Jens Huober, V 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB